Correction: Risk of developing checkpoint immune pneumonitis and its effect on overall survival in non-small cell lung cancer patients previously treated with radiotherapy
Abstract
Barrón F, Sánchez R, Arroyo-Hernández M, Blanco C, Zatarain-Barrón ZL, Catalán R, Ramos-Ramírez M, Cardona AF, Flores-Estrada D and Arrieta O (2020) Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy. Front. Oncol. 10:570233. doi:10.3389/fonc.2020.570233.In the published article, the "No. (Events)" values for the "Wood-smoke exposure" row and Pneumonitis rows in Table 3 were transcribed incorrectly during table formatting. The Cox analysis for wood-smoke exposure and both pneumonitis categories (any grade and ≥2) were performed with the correct underlying data; only the "No. (Events)" figures in that row are misprinted.
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Lung Cancer Diagnosis and Treatment
Ferroptosis and cancer prognosis
Publication details
- Journal / source
- Frontiers in Oncology
- Volume
- 16
- Pages
- 1783059–1783059
- Publication date
- 6 February 2026
- Language
- EN